Evidence map›Paper›PMID 18246198›Full record

ArticleThe Journal of clinical investigation2008

Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain.

Christian Zöllner, Shaaban A Mousa, Oliver Fischer, Heike L Rittner, Mohammed Shaqura, Alexander Brack, Mehdi Shakibaei, Waltraud Binder, Florian Urban, Christoph Stein and 1 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04213196 (A Phase I Clinical Study Evaluating the Safety, Tolerability and Pharmacokinetics of HSK21542 in Healthy Volunteers), which is not on this map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04213196 phase1completednot on this mapstarted 2020, after this paper: background citation

A Phase I Clinical Study Evaluating the Safety, Tolerability and Pharmacokinetics of HSK21542 in Healthy Volunteers

TypeinterventionalSponsorSichuan Haisco Pharmaceutical Group Co., LtdRan2020 to 2020Enrolled66ConditionsHealthy VolunteersArmsHSK21542
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 129 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Recent Advances in Peripheral Opioid Receptor Therapeutics.Current pain and headache reports · 2021
    Review
  13. Pharmacological Chaperones Attenuate the Development of Opioid Tolerance.International journal of molecular sciences · 2020
    Article
  14. Review
  15. Review
  16. Article
  17. Inflammation-associated changes in DOR expression and function in the mouse colon.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Article
  18. Opioids and the immune system - friend or foe.British journal of pharmacology · 2018
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Christian ZöllnerKlinik für Anaesthesiologie und operative Intensivmedizin, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany. christian.zoellner@charite.de
Shaaban A Mousa
Oliver Fischer
Heike L Rittner
Mohammed Shaqura
Alexander Brack
Mehdi Shakibaei
Waltraud Binder
Florian Urban
Christoph Stein
Michael Schäfer
Charité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although opioids are highly effective analgesics, they are also known to induce cellular adaptations resulting in tolerance. Experimental studies are often performed in the absence of painful tissue injury, which precludes extrapolation to the clinical situation. Here we show that rats with chronic morphine treatment do not develop signs of tolerance at peripheral mu-opioid receptors (micro-receptors) in the presence of painful CFA-induced paw inflammation. In sensory neurons of these animals, internalization of mu-receptors was significantly increased and G protein coupling of mu-receptors as well as inhibition of cAMP accumulation were preserved. Opioid receptor trafficking and signaling were reduced, and tolerance was restored when endogenous opioid peptides in inflamed tissue were removed by antibodies or by depleting opioid-producing granulocytes, monocytes, and lymphocytes with cyclophosphamide (CTX). Our data indicate that the continuous availability of endogenous opioids in inflamed tissue increases recycling and preserves signaling of mu-receptors in sensory neurons, thereby counteracting the development of peripheral opioid tolerance. These findings infer that the use of peripherally acting opioids for the prolonged treatment of inflammatory pain associated with diseases such as chronic arthritis, inflammatory neuropathy, or cancer, is not necessarily accompanied by opioid tolerance.

Indexed as

Animalsbeta-EndorphinCells, CulturedCyclophosphamideDrug ToleranceFentanylGuanosine 5'-O-(3-Thiotriphosphate)InflammationMaleMorphineNeurons, AfferentPainRatsRats, WistarReceptors, Opioid, mubeta-EndorphinCyclophosphamideFentanylGuanosine 5'-O-(3-Thiotriphosphate)MorphineReceptors, Opioid, mu

Identifiers

PMID18246198
PMCPMC2214843
OpenAlexW2033059080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.